The estimated Net Worth of Michael S Anderson is at least 3.48 百万$ dollars as of 10 August 2018. Michael Anderson owns over 16,297 units of Avadel Pharmaceuticals plc stock worth over 3,398,208$ and over the last 8 years Michael sold AVDL stock worth over 80,018$.
Michael has made over 6 trades of the Avadel Pharmaceuticals plc stock since 2017, according to the Form 4 filled with the SEC. Most recently Michael sold 16,297 units of AVDL stock worth 80,018$ on 10 August 2018.
The largest trade Michael's ever made was selling 16,297 units of Avadel Pharmaceuticals plc stock on 10 August 2018 worth over 80,018$. On average, Michael trades about 3,027 units every 41 days since 2016. As of 10 August 2018 Michael still owns at least 248,953 units of Avadel Pharmaceuticals plc stock.
You can see the complete history of Michael Anderson stock trades at the bottom of the page.
Michael's mailing address filed with the SEC is C/O FLAMEL TECHNOLOGIES S.A., 33, AVENUE DU DOCTEUR GEORGES LEVY, VENISSIEUX, I0, 69200.
Over the last 8 years, insiders at Avadel Pharmaceuticals plc have traded over 7,791,038$ worth of Avadel Pharmaceuticals plc stock and bought 775,568 units worth 4,366,224$ . The most active insiders traders include Healthcare Master Fund Ltd ...、Kevin Broadfin Capital, Llc...、Naseem Amin. On average, Avadel Pharmaceuticals plc executives and independent directors trade stock every 43 days with the average trade being worth of 381,436$. The most recent stock trade was executed by Thomas S Mchugh on 16 January 2024, trading 2,000 units of AVDL stock currently worth 29,000$.
avadel pharmaceuticals plc (nasdaq: avdl) is a specialty pharmaceutical company that seeks to develop differentiated pharmaceutical products that are safe, effective and easy to take, helping patients adhere to their prescribed medical treatment and see better results. avadel’s current portfolio of products and product candidates focuses on the urology, central nervous system (cns) / sleep, and hospital markets. the company is headquartered in dublin, ireland with operations in st. louis, missouri and lyon, france.
Avadel Pharmaceuticals plc executives and other stock owners filed with the SEC include: